Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 9/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5168911 | 0.85 | NPC1 (0.65) | ALDH1A1MAPTNPC1RAB9AHPGD | |
| SCHEMBL5172043 | 0.80 | POLB (0.56) | ALDH1A1MAPTNPC1RAB9AHPGD | |
| SCHEMBL9808095 | 0.80 | NPC1 (0.55) | ALDH1A1MAPTNPC1RAB9AHPGD | |
| SCHEMBL5169781 | 0.78 | POLB (0.54) | ALDH1A1MAPTNPC1RAB9AHPGD | |
| SCHEMBL28435021 | 0.78 | POLB (0.54) | ALDH1A1MAPTNPC1RAB9AHPGD | |
| SCHEMBL8362962 | 0.78 | NPC1 (0.53) | ALDH1A1MAPTNPC1RAB9AHPGD | |
| SCHEMBL8683926 | 0.76 | NPC1 (0.52) | ALDH1A1MAPTNPC1RAB9AHPGD | |
| SCHEMBL22755712 | 0.76 | NPC1 (0.57) | ALDH1A1MAPTNPC1RAB9AHPGD | |
| SCHEMBL22755713 | 0.76 | NPC1 (0.52) | ALDH1A1MAPTNPC1RAB9AHPGD | |
| SCHEMBL1740016 | 0.76 | NPC1 (0.52) | ALDH1A1MAPTNPC1RAB9AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117043140-A | Substituted pyrrolidin-2-ones, salts thereof and their use as herbicidal active substances | 拜耳公司 | 2023-11-10 | — | — | CN | disclosed |
| US-7141657-B2 | Azo compound, tautomer thereof, and azo dye | FUJIFILM CORPORATION (JP) | 2006-11-28 | — | — | US | disclosed |
| US-20060009627-A1 | Azo compound, tautomer thereof, and azo dye | FUJI PHOTO FILM CO., LTD. | 2006-01-12 | — | — | US | disclosed |
| US-20040220054-A1 | Recording material | FUJI PHOTO FILM CO., LTD. | 2004-11-04 | — | — | US | disclosed |
| EP-1473591-A1 | Recording material | FUJI PHOTO FILM CO., LTD. (JP) | 2004-11-03 | — | — | EP | disclosed |
| EP-0382213-B1 | Biphenyl derivative, nerve cell degeneration repairing or protecting agent and process for preparing a phenyl derivative contained in the agent | OTSUKA PHARMA CO LTD (JP) | 1995-05-10 | — | — | EP | disclosed |
| US-5053548-A | Containing hydroxy substituents; nervous system disorders | OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) | 1991-10-01 | — | — | US | disclosed |
| EP-0382213-A2 | Biphenyl derivative, nerve cell degeneration repairing or protecting agent and process for preparing a phenyl derivative contained in the agent | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060009627-A1 | Azo compound, tautomer thereof, and azo dye | NR4A1, PRMT7, NR0B1 | ALDH1A1 2042/4885MAPT 144/4885NPC1 3364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.